XML 51 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Compensation Plans and Stock Based Compensation (Tables)
12 Months Ended
Dec. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock based compensation expense and allocation by share based payment award
Stock-based compensation expense and the related income tax benefit recognized in connection with stock options, restricted stock and the ESPP during fiscal 2017, 2016 and 2015 were as follows:
 
2017
 
2016
 
2015
 
(In thousands)
Stock options
$
5,417

 
$
5,649

 
$
7,903

Restricted stock
117,797

 
96,989

 
78,615

ESPP
6,809

 
6,579

 
5,823

Total stock-based compensation expense
$
130,023

 
$
109,217

 
$
92,341

 
 
 
 
 
 
Income tax benefit
$
36,664

 
$
30,980

 
$
24,294

Stock based compensation expense and allocation by cost
Stock-based compensation expense is reflected in Cadence’s consolidated income statements during fiscal 2017, 2016 and 2015 as follows:
 
2017
 
2016
 
2015
 
(In thousands)
Cost of product and maintenance
$
2,218

 
$
1,995

 
$
2,436

Cost of services
3,232

 
2,911

 
3,561

Marketing and sales
26,838

 
22,700

 
21,654

Research and development
77,222

 
64,061

 
49,755

General and administrative
20,513

 
17,550

 
14,935

Total stock-based compensation expense
$
130,023

 
$
109,217

 
$
92,341

Fair value of options granted and the weighted-average assumptions
The weighted-average grant date fair value of options granted and the weighted-average assumptions used in the model for fiscal 2017, 2016 and 2015 were as follows:
 
2017
 
2016
 
2015
Dividend yield
None

 
None

 
None

Expected volatility
21.2
%
 
31.5
%
 
26.8
%
Risk-free interest rate
2.01
%
 
1.21
%
 
1.61
%
Expected term (in years)
4.8

 
4.8

 
5.0

Weighted-average fair value of options granted
$
6.86

 
$
5.84

 
$
4.60

Summary of changes in stock options outstanding under equity incentive plans
A summary of the changes in stock options outstanding under Cadence’s equity incentive plans during fiscal 2017 is presented below:
 
 
 
Weighted-
Average
 
Weighted-
Average
Remaining
Contractual
Terms
 



Aggregate
Intrinsic
 
Shares
 
Exercise Price
 
(Years)
 
Value
 
(In thousands)
 
 
 
 
 
(In thousands)
Options outstanding as of December 31, 2016
7,117

 
$
13.61

 
 
 
 
Granted
820

 
30.72

 
 
 
 
Exercised
(1,957
)
 
11.37

 
 
 
 
Canceled and forfeited
(197
)
 
20.52

 
 
 
 
Options outstanding as of December 30, 2017
5,783

 
$
16.56

 
3.8
 
$
110,114

Options vested as of December 30, 2017
4,104

 
$
13.72

 
3.2
 
$
89,790

Intrinsic value of and cash received from options exercised
The total intrinsic value of and cash received from options exercised during fiscal 2017, 2016 and 2015 was:
 
2017
 
2016
 
2015
 
(In thousands)
Intrinsic value of options exercised
$
45,643

 
$
44,835

 
$
67,363

Cash received from options exercised
22,255

 
30,984

 
52,261

Stock-based compensation expense related to performance-based restricted stock grants
Stock-based compensation expense related to performance-based restricted stock grants for fiscal 2017, 2016 and 2015 was as follows:
 
2017
 
2016
 
2015
 
(In thousands)
Stock-based compensation expense related to performance-based grants
$
8,224

 
$
9,195

 
$
5,544

Summary of the changes in restricted stock outstanding under Cadence's equity incentive plans
A summary of the changes in restricted stock outstanding under Cadence’s equity incentive plans during fiscal 2017, is presented below:
 
 
 
Weighted-
Average Grant Date
 
Weighted-
Average
Remaining
Vesting
Terms
 



Aggregate
Intrinsic
 
Shares
 
Fair Value
 
(Years)
 
Value
 
(In thousands)
 
 
 
 
 
(In thousands)
Unvested shares as of December 31, 2016
12,082

 
$
20.40

 
 
 
 
Granted
5,909

 
34.48

 
 
 
 
Vested
(5,121
)
 
20.75

 
 
 
 
Forfeited
(902
)
 
21.49

 
 
 
 
Unvested shares as of December 30, 2017
11,968

 
$
27.11

 
1.1
 
$
500,231

Total fair value of restricted stock awards that vested
The total fair value realized by employees upon vesting of restricted stock during fiscal 2017, 2016 and 2015 was:
 
2017
 
2016
 
2015
 
(In thousands)
Fair value of restricted stock realized upon vesting
$
174,548

 
$
113,114

 
$
99,564

Weighted-average grant date fair value of purchase rights granted under ESPP and weighted average assumptions used in model
The weighted-average grant date fair value of purchase rights granted under the ESPP and the weighted-average assumptions used in the model for fiscal 2017, 2016 and 2015 were as follows:
 
2017
 
2016
 
2015
Dividend yield
None

 
None

 
None

Expected volatility
20.4
%
 
24.4
%
 
22.9
%
Risk-free interest rate
0.92
%
 
0.43
%
 
0.13
%
Expected term (in years)
0.5

 
0.5

 
0.5

Weighted-average fair value of options granted
$
6.64

 
$
4.85

 
$
4.23

Shares of common stock issued under Employee Stock Purchase Plan
Shares of common stock issued under the ESPP for fiscal 2017, 2016 and 2015 were as follows:
 
2017
 
2016
 
2015
 
(In thousands, except per share amounts)
Cadence shares purchased under the ESPP
1,270

 
1,471

 
1,519

Cash received for the purchase of shares under the ESPP
$
26,709

 
$
24,450

 
$
22,449

Weighted-average purchase price per share
$
21.04

 
$
16.62

 
$
14.78

Summary of common stock reserved for future issuance
As of December 30, 2017, Cadence had reserved the following shares of authorized but unissued common stock for future issuance:
 
Shares
 
(In thousands)
Employee equity incentive plans*
18,663

Employee stock purchase plans
3,920

Directors stock plans*
1,298

    Total
23,881

_____________
* Includes shares reserved for: (i) issuance upon exercise of future option grants, (ii) issuance upon vesting of future restricted stock grants, (iii) outstanding but unexercised options to purchase common stock, or (iv) unvested restricted stock units.